| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| Di | MEDTECS INTERNATIONAL CORP LTD: CHANGE - ANNOUNCEMENT OF CESSATION::RESIGNATION OF INDEPENDENT DIRECTOR | 1 | SGX Company Announcements | ||
| Mo | MEDTECS INTERNATIONAL CORP LTD: ANNUAL REPORTS AND RELATED DOCUMENTS | 3 | SGX Company Announcements | ||
| Mo | MEDTECS INTERNATIONAL CORP LTD: ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
| Fr | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::TERMINATION OF JOINT VENTURE WITH SHIJIAZHUANG HONGRAY GROUP CO., LTD. | 1 | SGX Company Announcements | ||
| MEDTECS Aktie jetzt für 0€ handeln | |||||
| Fr | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::TERMINATION OF JOINT VENTURE WITH SHIJIAZHUANG HONGRAY GROUP CO., LTD. | - | SGX Company Announcements | ||
| 26.02. | MEDTECS INTERNATIONAL CORP LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
| 11.02. | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::MONTHLY UPDATE PURSUANT TO CATALIST RULE 704(22) | 2 | SGX Company Announcements | ||
| 29.01. | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::MONTHLY UPDATE PURSUANT TO CATALIST RULE 704(22) | - | SGX Company Announcements | ||
| 28.01. | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD OF DIRECTORS AND BOARD COMMITTEES | 2 | SGX Company Announcements | ||
| 28.01. | MEDTECS INTERNATIONAL CORP LTD: CHANGE - ANNOUNCEMENT OF CESSATION::RESIGNATION OF INDEPENDENT DIRECTOR | 1 | SGX Company Announcements | ||
| 28.01. | MEDTECS INTERNATIONAL CORP LTD: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF INDEPENDENT DIRECTOR | 2 | SGX Company Announcements | ||
| 29.12.25 | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::MONTHLY UPDATE PURSUANT TO CATALIST RULE 704(22) | - | SGX Company Announcements | ||
| 16.12.25 | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::UPDATE ON JOINT VENTURE WITH SHIJIAZHUANG HONGRAY GROUP CO., LTD. | 1 | SGX Company Announcements | ||
| 24.11.25 | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::MONTHLY UPDATE PURSUANT TO CATALIST RULE 704(22) | 1 | SGX Company Announcements | ||
| 29.10.25 | MEDTECS INTERNATIONAL CORP LTD: GENERAL ANNOUNCEMENT::MONTHLY UPDATE PURSUANT TO CATALIST RULE 704(22) | 1 | SGX Company Announcements | ||
| 02.10.25 | Medtecs International Corporation Limited: Medtecs Showcases Global Capabilities at MEDICA and A+A in Germany | 280 | PR Newswire | TAIPEI, Oct. 2, 2025 /PRNewswire/ -- The rapid advancement of digitalization and smart healthcare is reshaping the global medical industry, where stable production, continuous product innovation... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 46,010 | -0,07 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| GERRESHEIMER | 21,220 | +19,89 % | XETR EXTRAORDINARY MODIFICATIONS OF SHARE INDICES EFFECTIVE 10. APRIL 2026 | For the following instruments, the Product Assignment Group in Xetra (MIC: XETR) will change with effect from 10. April 2026 Instrument Mnemonic ISIN Product Assignment Group (old) Product Assignment... ► Artikel lesen | |
| BILLIONTOONE | 80,61 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 | ||
| FRESENIUS | 44,310 | +0,64 % | FRESENIUS SE & CO KGAA: Struktur in der Ruhe | ||
| FRESENIUS MEDICAL CARE | 38,580 | -0,28 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 13,020 | +10,20 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,330 | -0,03 % | SIEMENS HEALTHINEERS AG im strategischen Gleichgewicht | ||
| HEARTFLOW | 29,190 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,700 | +4,51 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| GENEDX | 67,32 | +0,69 % | Jefferies bestätigt Kaufempfehlung für GeneDx und verweist auf geringe Marktdurchdringung | ||
| PROGYNY | 17,400 | +1,34 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| HIMS & HERS HEALTH | 22,260 | +8,06 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,920 | -1,69 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,290 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Notification regarding unquoted securities - AVR | ||
| RXSIGHT | 7,215 | -0,76 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |